Michel Vaillant
About
In The Last Decade
Michel Vaillant
114 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 144
- Public Health, Environmental and Occupational Health 1.1k
- Epidemiology 825
- Parasitology 429
- Neurology 402
- Physiology 388
Countries citing papers authored by Michel Vaillant
This map shows the geographic impact of Michel Vaillant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vaillant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vaillant more than expected).
Fields of papers citing papers by Michel Vaillant
This network shows the impact of papers produced by Michel Vaillant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vaillant. The network helps show where Michel Vaillant may publish in the future.
Co-authorship network of co-authors of Michel Vaillant
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vaillant. A scholar is included among the top collaborators of Michel Vaillant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vaillant. Michel Vaillant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 15 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 11 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 18 | |
| 11 | 3 | |
| 12 | 10 | |
| 13 | 63 | |
| 14 | Efficacy of a single oral dose of 8 mg Moxidectin vs. 150 mu g/kg ivermectin in onchocerca volvulus infection: results of a randomized, double-blind single dose phase 3 study in areas without mass treatment with ivermectin in Liberia, Ghana and DRC | 3 |
| 15 | 239 | |
| 16 | CHANGES IN MALARIA IN SOUTHERN SENEGAL WITH THE INTRODUCTION OF ARTESUNATE PLUS AMODIAQUINE AND PARASITOLOGICAL DIAGNOSIS | 1 |
| 17 | 37 | |
| 18 | Combination liposomal amphotericin B (AmBisome (R), AmB) and miltefosine (MF) for the treatment of visceral leishmaniasis (VL) in northern Bihar, India | 1 |
| 19 | 31 | |
| 20 | Artesunate (AS) plus amodiaquine (AQ) for treating falciparum malaria - Assessing its efficacy and tolerability during six years of field deployment in southern Senegal | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.